Clinical Trial Update: Evaluate the Efficacy and Safety of Combination Treatment With DW1501-R1+DW1501-R2 Versus DW1501-R1 or DW1501-R2+DW1501-R3 in Patients With Hypertension and Dyslipidemia [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating a combination therapy for hypertension and dyslipidemia; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia
• Hypertension

Drugs mentioned

• DW1501-R1
• DW1501-R2
• DW1501-R3

Snippet

Sponsor: Daewon Pharmaceutical Co., Ltd. | Conditions: Hypertension, Dyslipidemia | Phase 3 | Status: COMPLETED